Literature DB >> 15930819

LC-MS determination and pharmacokinetic studies of ursolic acid in rat plasma after administration of the traditional chinese medicinal preparation Lu-Ying extract.

Qiongfeng Liao1, Wei Yang, Ying Jia, Xiaohui Chen, Qiutao Gao, Kaishun Bi.   

Abstract

Sambucus chinensis L. is a native perennial herb distributed throughout China. In traditional Chinese medicine (TCM), this herb is known as Lu-Ying. Ursolic acid is the major effective constituent of Lu-Ying. A rapid, sensitive, and accurate liquid chromatography-mass spectrometry (LC-MS) method for the determination of ursolic acid in rat plasma was developed and validated. Plasma samples taken from rats that had received Lu-Ying extract orally were acidified with acetic acid and then extracted with a mixture of hexane-dichloromethane-2-propanol (20:10:1, v/v/v). Separation of ursolic acid was accomplished on a C(18) column interfaced with a single quadrupole mass spectrometer. The mobile phase consisting of methanol and water (95:5, v/v) was delivered at a flow rate of 1.0 ml/min. Atmospheric pressure chemical ionization was operated in negative-ion mode. Using selected ion-monitoring mode, the deprotonated molecules [M-H](-) at m/z 455 and 469 were used to quantify ursolic acid and glycyrrhetic acid (internal standard), respectively. The assay was shown to be linear over the range of 10-1000 ng/ml (r> or =0.9960) with a lower limit of quantification of 10 ng/ml. The method was shown to be reproducible and reliable with intraday precision below 7.8%, interday precision below 8.1%, accuracy within +/-4.3%, and mean extraction recovery excess of 83.6%, which were all calculated from the blank plasma sample spiked with ursolic acid at three concentrations of 20, 200, and 800 ng/ml. The LC-MS method has been successfully applied to pharmacokinetic studies of ursolic acid after oral administration of Lu-Ying ethanolic extract (at a dose containing 80.32 mg/kg ursolic acid) to rats. The main pharmacokinetic parameters were: t(1/2), 4.3 h; K(e), 0.16 1/h; t(max), 1.0 h; C(max), 294.8 ng/ml; AUC(0-t) and AUC(0-infinity), 1007.1 ng.h/ml and 1175.3 ng.h/ml, respectively.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15930819     DOI: 10.1248/yakushi.125.509

Source DB:  PubMed          Journal:  Yakugaku Zasshi        ISSN: 0031-6903            Impact factor:   0.302


  17 in total

1.  Rapid and Sensitive Quantification of Ursolic Acid and Oleanolic Acid in Human Plasma Using Ultra-performance Liquid Chromatography-Mass Spectrometry.

Authors:  Larissa Stebounova; Scott M Ebert; Logan T Murry; Christopher M Adams; Daryl J Murry
Journal:  J Chromatogr Sci       Date:  2018-08-01       Impact factor: 1.618

2.  The effect of herbal medicine danshensu and ursolic acid on pharmacokinetics of rosuvastatin in rats.

Authors:  Jin-Hua Wen; Yu-Qing Xiong
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-06-30       Impact factor: 2.441

3.  Permeability of rosmarinic acid in Prunella vulgaris and ursolic acid in Salvia officinalis extracts across Caco-2 cell monolayers.

Authors:  Zhiyi Qiang; Zhong Ye; Cathy Hauck; Patricia A Murphy; Joe-Ann McCoy; Mark P Widrlechner; Manju B Reddy; Suzanne Hendrich
Journal:  J Ethnopharmacol       Date:  2011-07-20       Impact factor: 4.360

4.  Ursolic acid inhibits multiple cell survival pathways leading to suppression of growth of prostate cancer xenograft in nude mice.

Authors:  Muthu K Shanmugam; Peramaiyan Rajendran; Feng Li; Tarang Nema; Shireen Vali; Taher Abbasi; Shweta Kapoor; Ashish Sharma; Alan Prem Kumar; Paul C Ho; Kam M Hui; Gautam Sethi
Journal:  J Mol Med (Berl)       Date:  2011-04-05       Impact factor: 4.599

5.  Anti-cancer effect of ursolic acid activates apoptosis through ROCK/PTEN mediated mitochondrial translocation of cofilin-1 in prostate cancer.

Authors:  Wen-Tao Gai; Da-Peng Yu; Xin-Sheng Wang; Pei-Tao Wang
Journal:  Oncol Lett       Date:  2016-08-16       Impact factor: 2.967

Review 6.  Epigenetics/epigenomics of triterpenoids in cancer prevention and in health.

Authors:  Shanyi Li; Hsiao-Chen Dina Kuo; Ran Yin; Renyi Wu; Xia Liu; Lujing Wang; Rasika Hudlikar; Rebecca Mary Peter; Ah-Ng Kong
Journal:  Biochem Pharmacol       Date:  2020-02-29       Impact factor: 5.858

7.  Ursolic acid inhibits the initiation, progression of prostate cancer and prolongs the survival of TRAMP mice by modulating pro-inflammatory pathways.

Authors:  Muthu K Shanmugam; Tina H Ong; Alan Prem Kumar; Chang K Lun; Paul C Ho; Peter T H Wong; Kam M Hui; Gautam Sethi
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

8.  A phase I pharmacokinetic study of ursolic acid nanoliposomes in healthy volunteers and patients with advanced solid tumors.

Authors:  Zhongling Zhu; Zhengzi Qian; Zhao Yan; Cuicui Zhao; Huaqing Wang; Guoguang Ying
Journal:  Int J Nanomedicine       Date:  2013-01-04

9.  In vivo pharmacokinetic comparisons of ferulic acid and puerarin after oral administration of monomer, medicinal substance aqueous extract and Nao-De-Sheng to rats.

Authors:  Zhen Ouyang; Ming Zhao; Jianming Tang; Lulin Pan
Journal:  Pharmacogn Mag       Date:  2012-10       Impact factor: 1.085

10.  Ursolic acid, a natural pentacyclic triterpenoid, inhibits intracellular trafficking of proteins and induces accumulation of intercellular adhesion molecule-1 linked to high-mannose-type glycans in the endoplasmic reticulum.

Authors:  Satoshi Mitsuda; Tomonobu Yokomichi; Junpei Yokoigawa; Takao Kataoka
Journal:  FEBS Open Bio       Date:  2014-02-22       Impact factor: 2.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.